ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,016Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 63

$570K Total Retail Price of All Prescriptions

Rank: 6 out of 63

217 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 217 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

5% of this provider’s 217 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

2% of this provider’s 5,946 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
LEVOTHYROXINE SODIUM 263 206 1 1
FUROSEMIDE 251 221 2 4
DIVALPROEX SODIUM 221 117 3 35
TRAMADOL HCL 212 185 4 12
OLANZAPINE 184 99 5 56
RISPERIDONE 181 83 6 33
METOPROLOL TARTRATE 169 129 7 7
OMEPRAZOLE 158 109 8 6
AMLODIPINE BESYLATE 152 151 9 3
SERTRALINE HCL 131 103 10 19
LISINOPRIL 123 86 11 2
QUETIAPINE FUMARATE 115 73 12 34
DIOVAN 113 99 13 41
LANTUS 108 93 14 29
TRAZODONE HCL 106 51 15 18
BENZTROPINE MESYLATE 103 17 R 16 92
MIRTAZAPINE 100 89 17 8
RANITIDINE HCL 94 64 18 27
ATORVASTATIN CALCIUM 93 71 19 10
KLOR-CON M20 92 68 20 31
ADVAIR DISKUS 86 71 21 42
FLUOXETINE HCL 81 50 22 93
CITALOPRAM HBR 78 58 23 11
HALOPERIDOL 73 20 24 97
POLYETHYLENE GLYCOL 3350 72 67 25 38
DONEPEZIL HCL 71 52 26 14
METFORMIN HCL 68 40 27 17
TAMSULOSIN HCL 67 61 28 26
PAROXETINE HCL 66 32 29 71
POTASSIUM CHLORIDE 62 39 30 30
SIMVASTATIN 60 46 31 5
CLONIDINE HCL 60 45 31 49
NAMENDA 59 35 33 24
ZOLPIDEM TARTRATE 59 55 33 40
GENERLAC 52 41 35 103
SULFAMETHOXAZOLE-TRIMETHOPRIM 51 39 36 66
SEROQUEL 50 31 37 69
IBUPROFEN 50 49 37 100
AMITIZA 50 26 37 165
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.